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Abstract
Interleukin^7 cIL7d plays a non^redundant role in T cell survival and homeostasis, which is illustrated in the severe
T cell lymphopenia of IL7^deficient mice, or demonstrated in animals or humans that lack expression of either the
IL7Rα or γc chain, the two subunits that constitute the functional IL7 receptor. Remarkably, IL7 is not expressed by
T cells themselves, but produced in limited amounts by radio^resistant stromal cells. Thus, T cells need to constantly
compete for IL7 to survive. How T cells maintain homeostasis and further maximise the size of the peripheral T cell
pool in face of such competition are important questions that have fascinated both immunologists and mathemati^
cians for a long time. Exceptionally, IL7 down^regulates expression of its own receptor, so that IL7^signalled T cells
do not consume extra^cellular IL7, and thus, the remaining extra^cellular IL7 can be shared among unsignalled T cells.
Such an altruistic behaviour of the IL7Rα chain is quite unique between members of the γc cytokine receptor family.
However, the consequences of this altruistic signalling behaviour at the molecular, single cell and population levels
are less well understood and require further investigation. In this regard, mathematical modelling of how a limited
resource can be shared, while maintaining the clonal diversity of the T cell pool, can help decipher the molecular
or cellular mechanisms that regulate T cell homeostasis. Thus, the current review aims to provide a mathematical
modelling perspective of IL7^dependent T cell homeostasis at the molecular, cellular and population levels, in the
context of recent advances in our understanding of the IL7 biology.
1 Introduction
The IL7 receptor cIL7Rd and its ligand, IL7, are essential and non^redundant drivers of T cell development and
homeostasis e1, 2, 3, 4, 5, 6f. While T cells critically depend on IL7R signalling, IL7 itself is not expressed by T cells.
Instead, IL7 is mostly expressed by stromal cells and non^T lineage lymphoid and myeloid cells e7f, and the amount
of IL7 production is considered to be developmentally set e8, 9f. Consequently, IL7 signalling at the single cell level
is primarily controlled by IL7 receptor expression, and secondarily by IL7 availability in vivo. Thus, interrogating
the molecular basis of IL7 receptor expression and regulation is important to understand the role of IL7 receptor
signalling in T cell immunity.
The functional IL7 receptor is composed of the IL7^specific IL7Rα chain cCD127d and the common γ^chain cγc or
CD132d, which is shared with a series of other cytokines that include IL^2, IL^4, IL^9, IL15, and IL^21 e10f. Since
γc expression is presumed to be constitutive and also found in significant amounts on all T cells e11f, much of the
past and current studies of IL7 signalling have been focused on the regulatory mechanisms of the IL7Rα chain.
Notably, the IL7 receptor harbours many unique features that complicate the assessment of IL7R signalling and its
downstream eôects. Among others, IL7 receptor signalling down^regulates expression of its own receptor, so that IL7
signalling leads to suppression of further IL7R signalling e12f. Initiating such a negative regulatory feedback is quite
unusual, because expression of most other members of the γc receptor family is up^regulated by their cognate cytokine
signals e13f. Recent studies have shown that such unique behaviour profoundly aôects the kinetics and magnitude of
IL7 receptor signalling, and that this regulatory mechanism is essential to maintain normal T cell development and
homeostasis e14, 12, 15f. In fact, IL7^induced down^regulation of IL7R prevents IL7 signalled T cells from further
consumption of extra^cellular IL7, so that the limited amount of free IL7 can be shared among unsignalled T cells.
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Such altruistic behaviour of the IL7R seems required to maximise the size and diversity of the peripheral T cell
pool e12f. However, a greater understanding of the quantitative and qualitative immunological signalling eôects,
under continuous de^sensitisation and re^sensitisation of the IL7 receptor, requires stratification of the IL7 signalling
components. We consider that assessing these issues at the molecular, single cell and population levels will benefit
from mathematical modelling of this complex immune signalling pathway. Additionally, IL7Rα not only interacts
with its ligand but also binds directly to γc proteins in the absence of IL7 e16, 17f. As a result, IL7Rα and γc can
exist as a pre^associated, inactive receptor complex on the cell membrane, even prior to ligand engagement e16, 17f.
Receptor pre^association brings in a couple of new variables into the circuitry of IL7R signalling. Since the γc chain
is a shared component of multiple cytokines, pre^association of γc with IL7Rα would sequester the γc chain from
association with other cytokine receptors, such as IL15Rβ, and could interfere with their signalling capability in
trans. Moreover, IL7Rα/γc pre^association would change the IL7 binding a~nity of IL7Rα, so that free IL7Rα
proteins would have lower IL7 a~nities than IL7Rα complexed with γc. Because on the cell surface the number of
IL7Rα molecules is thought to vastly outnumber that of γc proteins e18f, under such a scenario, there would be two
diôerent species of IL7Rα chains, i.e., free and γc^complexed, on the cell surface. Significantly, the free form would
be signalling^incompetent and could act as an IL7 scavenger. On the other hand, the γc pre^associated form would
be signalling^competent, but outnumbered by un^associated IL7Rα proteins. How cellular exposure to IL7 would
initiate signalling in cells that express a mixture of two distinct receptor species is an important question that could
be addressed making use of the mathematical modelling methods presented in this review at the molecular, cellular
and population scales csee Section 5.1d.
Finally, enforced IL7 receptor expression does not promote, but paradoxically, inhibits both development and home^
ostasis of T cells e14, 15f. Whether this is due to excessive IL7 signalling on a per cell basis that would be detrimental
for cell survival e15f, or because of excessive IL7 consumption on a population basis, that would further limit IL7
availability e12f, still needs to be clarified e19f. In addition, the IL7Rα chain has no intrinsic signalling capability and
requires association with the tyrosine kinase JAK1, through its cytosolic tail, to trigger downstream signalling. But
JAK1 proteins are unstable due to microRNA controlled post^transcriptional mechanisms, and this could potentially
limit their availability for IL7Rα e20f. Thus, in addition to the extra^cellular events that control IL7 signalling at the
level of receptor and ligand association, the roles of intra^cellular components in the IL7R signalling machinery must
also be considered csee Section 5.1d.
Collectively, interrogating how these unique aspects of IL7 receptor signalling are interweaved in the control of T cell
development and homeostasis is essential to unravel the basic mechanisms that regulate T cell^mediated immune
responses at both the single cell and population levels. Computational and mathematical models of the dynamical
interactions between these many elements cimmune molecules and cellsdd have tremendously contributed to our
understanding of cytokine receptor signalling e21, 22, 23, 18, 24, 25f, and quantitative approaches and tools are also
essential and required to dissect the contribution of individual nodes in the IL7 signalling pathway.
In this review, we highlight the current state of our knowledge of the basic IL7 receptor biology and focus on the
role IL7 and IL7R have on mature CD8+ T cells as drivers of survival and homeostasis. Furthermore, we document
recent advances in the mathematical and computational modelling of IL7 receptor signalling and its application in
furthering our understanding of the dynamics of immune receptor signalling at the molecular csee Section 5.1d, cellular
csee Section 5.2d and population levels csee Section 5.3d.
2 IL7 receptor expression and function in T cell development and home_
ostasis
The signalling^competent IL7 receptor is a hetero^dimeric protein complex, composed of the specific IL7Rα chain
and the γc receptor. In contrast to γc expression, IL7Rα expression is dynamically regulated during T cell develop^
ment and diôerentiation, so that IL7Rα expression is the primary determinant of IL7 responsiveness e19f. During
thymocyte development, IL7Rα is highly expressed on the most immature CD4, CD8+ double^negative cDNd cells,
but then terminated upon diôerentiation into CD4, CD8+ double^positive cDPd cells e26, 27, 28f. IL7Rα signalling
is required in immature DN cells to provide critical pro^survival and proliferative cues e1, 29f. However, continued
IL7Rα expression on DP thymocytes is detrimental to T cell development, since it would interfere with selection
of a T cell receptor cTCRd^dependent immunocompetent repertoire e14, 30f. The molecular mechanism that termi^
nates IL7Rα protein expression and transcription on DP thymocytes is not known e31f. Interestingly, this feature
is not evolutionary conserved, because DP thymocytes in humans express robust amounts of IL7Rα proteins e32f.
Nonetheless, immature DP thymocytes in humans show dramatic down^regulation of γc protein expression, which
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renders these cells IL7 unresponsive e32f. Thus, suppression of IL7R signalling in DP thymocytes is a common char̂
acteristic in both mice and humans, but that is achieved through diôerent means.
TCR^induced positive selection results in re^expression of IL7Rα on both CD4+ and CD8+ lineage T cells e26f.
Concomitant to IL7Rα upregulation, CD8+ lineage committed thymocytes become IL7^responsive. CD4+ lineage
committed cells, on the other hand, remain IL7 unresponsive despite expressing large amounts of IL7Rα. In fact, it is
the selective de^sensitisation of cytokine receptors in CD4+ lineage cells that determines CD4/CD8+ lineage choice
in the thymus and imposes CD4+ lineage choice e33f. Mechanistically, it was recently demonstrated that expression
of the CD4+ lineage^specific transcription factor ThPOK induces expression of Suppressor Of Cytokine Signalling
cSOCSd genes, which in turn suppresses IL7R signalling to prevent up^regulation of the CD8^specifying transcription
factor Runx3 e34f. Thus, surface IL7Rα expression does not necessarily guarantee productive IL7R signalling. Along
this line, cytokine receptor de^sensitisation is another mechanism that needs to be considered to understand IL7
receptor signalling.
Multiple mechanisms have been proposed to induce de^sensitisation of IL7Rα signalling. Persistent TCR signalling
that leads to destabilisation of IL7Rα^associated JAK1 expression, or up^regulation of SOCS1 expression to inhibit
JAK kinase activity, and proteolytic cleavage of the γc chain cytosolic tail by the cysteine protease, calpain, are some
of the proposed, and not necessarily mutually exclusive, mechanisms e35, 36, 20f. During thymocyte diôerentiation,
regaining IL7 responsiveness is critical for CD8+ single positive cSPd thymocyte generation because impaired IL7
signalling, either by enforced expression by SOCS1 or by conditional deletion of IL7Rα in pre^selection thymocytes,
resulted in profoundly impaired generation of CD8+ lineage cells e5, 27, 34f. The prerequisite for IL7 signalling in
CD8+ cells is mostly due to a STAT5 requirement, which up^regulates expression of Runx3 and induces expression of
a series of pro^survival molecules, including Bcl^2 and Mcl^1 e37, 38f. However, IL7 also activates other downstream
signalling pathways, such as PI^3K and NFATc1, which contribute to cell survival by up^regulation of anti^apoptotic
molecules and trophic factors, including expression of the glucose transporter̂ 1 e39, 40, 41f.
Upon their generation in the thymus, T cells move out to peripheral tissues but they remain addicted to IL7 through^
out their life. Thus, maintaining high levels of IL7Rα expression on mature T cells is critical for T cell survival. How^
ever, the regulatory mechanism of IL7Rα transcription is quite distinct between thymocytes and peripheral T cells.
Previously, an evolutionary conserved enhancer element, CNS1, had been identified that sits 3.6 kb upstream of the
IL7Rα promoter e42f, and which was found to be controlled by multiple factors, including FoxO1 and Foxp1, as well
as glucocorticoids e42, 43, 44f. Remarkably, deletion of CNS1 resulted in dramatic loss of IL7Rα expression and
significantly reduced T cell numbers in the periphery, but did not aôect IL7Rα expression on thymocytes or de^
creased thymic cellularity e45f. These results suggested the use of distinct molecular mechanisms to control IL7Rα
chain expression on immature and mature T cells, and also echo previous observations of diôerent IL7Rα regulatory
mechanisms between CD4+ and CD8+ T cells e12, 31f and also B and T lineage cells e46, 47f. Thus, IL7Rα expression
is regulated in a highly specific manner, depending on the developmental stage and possibly also on the activation
status of T cells.
3 Regulation of IL7 receptor expression
A distinguishing feature of IL7Rα from other cytokine receptors of the γc family is the down^regulation of its own
expression by cognate cytokine signalling e12f. In fact, not only IL7, but other γc cytokines also transcriptionally sup^
press IL7Rα e47, 12f. IL7^induced down^regulation of IL7Rα expression is further accelerated by rapid endocytosis
and degradation of IL7^associated IL7Rα proteins, so that IL7 induces a negative regulatory feedback loop for IL7
receptor signalling e48, 49f. Considering the critical role of IL7 in T cell survival and the limited availability of IL7
in vivo, it seems paradoxical that IL7 signalling would terminate further IL7 signalling.
Two distinct but not mutually exclusive hypotheses have been put forward to explain the self^limiting nature of
IL7 receptor signalling on T cells. The first model proposes that T cells constrain IL7 signalling and consumption
to maximise the use of limited extra^cellular IL7 and to maintain clonal diversity of the mature peripheral T cell
pool e12f. By preventing excess consumption of IL7 and clonal outgrowth of T cells that have better access to IL7, on
a population basis, IL7^induced IL7Rα down^regulation would maximise the size of the T cell pool, while maintaining
a high degree of TCR clonal diversity. Thus, IL7Rα down^regulation would be beneficial for a population, but not
for individual T cells per se. Contrary to this idea, the second model proposes that sustained IL7 signalling would
be detrimental for individual T cells, and that termination of prolonged IL7 signalling is necessary for survival. In
fact, in vivo transfer experiments and in vitro proliferation assays with IL7Rα transgenic T cells demonstrated that
the inability to down^regulate IL7Rα expression resulted in cytokine^induced cell death of T cells e15f. Specifically,
continuous IL7R signalling in CD8+ T cells resulted in their uncontrolled proliferation and rapid diôerentiation
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into eôector cytolytic T cells that produced large amounts of interferons and induced cell death. In agreement,
IL7Rα^transgenic mice also contain a significantly reduced size of T cell pool in the periphery e12, 15f.
The molecular mechanisms that lead to suppression of IL7Rα expression have been assessed, and at least for CD8+
T cells, it was found to be dependent on the zinc finger transcription factor Gfi1 e12f. CD8+ T cells in Gfi1^deficient
mice expressed high levels of IL7Rα, while CD8+ T cells in Gfi1^transgenic mice showed reduced IL7Rα tran^
scription and expression e38, 31f. The cellular factors that control IL7Rα suppression in CD4+ T cells are less well
known. But reportedly, the forkhead box family transcription factor Foxp3 down^regulates IL7Rα expression on
Foxp3+ T regulatory CD4+ T cells e50f, and Foxp1 can suppress IL7Rα by antagonising Foxo1 e44f. The precise
transcriptional pathway that controls IL7Rα downstream of IL7 and other cytokine signals remains to be mapped.
4 IL7 receptor signalling
Both IL7Rα and γc chains lack intrinsic kinase activities. Rather, they require activation of the tyrosine kinases JAK1
and JAK3, which are constitutively associated with the cytosolic tails of IL7Rα and γc, respectively, to transduce IL7
signalling e10f. Upon ligand^induced IL7Rα/γc hetero^dimerisation, JAK1 and JAK3 trans^activate each other, and
subsequently phosphorylate the intracellular tail of IL7Rα. There are three conserved tyrosine residues in the IL7Rα
cytosolic domain, but tyrosine 449 is the major substrate of IL7Rα phosphorylation e51f. Phosphorylation of IL7Rα
Tyr449 leads to the creation of STAT5 and PI^3^kinase binding sites, resulting in the recruitment and subsequent
phosphorylation and activation of these factors e52, 51f.
Due to their distinct ligand binding a~nities and association with diôerent JAK molecules, the individual contribu^
tion of each IL7R subunit to IL7 signalling also diôers. The γc chain contributes to IL7 receptor signalling through
two major activities. Firstly, it serves to bring JAK3 into the receptor signalling complex, which trans^activates
IL7Rα^bound JAK1 e10f. Secondly, γc dramatically increases the a~nity of the IL7 receptor complex for IL7. In
the absence of γc, IL7Rα binds IL7 with a low a~nity e53f cKd = 2.4 × 10−10 Md. However, inclusion of γc sig^
nificantly increases the a~nity for IL7 cKd = 4 × 10−11 Md, which results in the preferential capture of IL7 by
signalling^competent IL7 receptors compared to signalling^incompetent γc^free IL7Rα chain proteins. Whether
the high a~nity IL7Rα/γc complex is only formed upon ligand binding, or whether such high a~nity IL7 receptor
could be already assembled and expressed on the cell surface is currently a much^debated issue in cytokine biology.
The conventional view posits that the IL7Rα/γc complex is formed by stepwise assembly that is triggered by IL7
binding to the IL7Rα chain e54f. In this model, the IL7Rα and γc proteins are diôusely distributed in the plasma
membrane prior to ligand engagement. Upon IL7 stimulation, IL7Rα binds IL7 with low a~nity and undergoes a
conformational change that attracts the γc chain, which in turn stabilises IL7 binding, to initiate IL7R signalling.
The formation of a hetero^trimeric complex of IL7/IL7Rα/γc brings the intra^cellular tails of IL7Rα and γc into
proximity, which juxtapositions and activates JAK1 and JAK3 to initiate downstream signalling.
In an alternative view, it has been proposed that IL7Rα and γc can bind even in the absence of IL7, so that γc
proteins are already sequestered and associated with IL7Rα e16, 55f. In fact, crystallographic studies of the IL7Rα/γc
receptor complex postulated that IL7Rα and γc proteins exist as pre^formed, inactive receptor complexes prior to
ligand engagement e16f. In this model, ligand^free IL7Rα and γc associate in a “head^to^head” configuration that
pushes away the trans^membrane domains and intra^cellular tails of IL7Rα and γc, and thus, prevents spontaneous
ligand^independent activation of JAK1 and JAK3. Upon IL7 binding, however, the pre^associated IL7Rα/γc complex
undergoes a conformational change that erects the receptor complex and brings the intra^cellular tails of IL7Rα/γc
into close proximity and initiates downstream signalling e16f.
Currently, it is not clear which one of these strategies is employed by T cells for IL7 receptor signalling. Direct binding
of IL7Rα to γc proteins on the cell surface could be potentially visualised and quantified by FRET cFluorescence
Resonance Energy Transferd microscopy. Alternatively, methods such as PLA cProximity Ligation Assaysd could be
also employed to demonstrate pre^assembly of γc with IL7Rα e56f. At least in human CD4+ T cells, IL7Rα could be
co^immunoprecipitated with γc in the absence of IL7, which is in support of the IL7Rα/γc pre^association model e57f.
Whether a stepwise assembly model, where initially all surface IL7 receptors have the same a~nity to IL7, or the
pre^assembly model, where two classes of IL7 receptor exist and the functionally competent IL7Rα/γc complexes
would out^compete low a~nity IL7Rα receptors, would be more biologically meaningful is not clear. However,
we consider this question precisely an area where mathematical modelling can be employed in the near future to
compare and test these diôerent hypotheses cor mechanismsd together with empirical data. Thus, in the following
section, we illustrate the power of a quantitative mathematical approach by modelling the molecular regulation of
IL7R signalling under the scenario where two homeostatic γc family cytokines, namely IL7 and IL15, compete for the
γc chain csee Section 5.1d. At the single cell level, we quantify the eôect of the altruistic hypothesis on the number of
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IL7R molecules expressed on the membrane of T cells csee Section 5.2d. Finally, at the population scale, we model the
heterogeneity of T cell responses to IL7 stimulation observed in Ref. e58f, where IL7 availability and the existence of
survival and proliferation thresholds can influence the population dynamics of IL7 dependent T cells csee Section 5.3d.
5 Mathematical models at the molecular, cellular and population lev_
els
5.1 Mathematical model at the molecular level
At the molecular level, we are interested in understanding the role of shared components in immune signalling e22f.
In the case of IL7R signalling, a first shared component is the γc chain, which is part of the hetero^dimeric receptors
IL7R and IL15R csee Fig. 1d. The γc chain is also part of the hetero^trimeric receptor IL2R e59f. In this review, we
have chosen to consider the IL15R as a shared component of the IL7 signalling pathway, since there already exists a
significant mathematical eôort to describe the IL2R one e60, 23, 61, 62, 25f.
Let us now describe the shared elements of IL7R and IL15R. In principle, the γc receptor subunit can bind to either





















Figure 1: An example of shared molecular components in immune signalling: competition for the γc chain by the
IL7Rα and IL15Rβ chains cadapted from Ref. e22fd.
Although γc contributes with the same stoichiometry to each hetero^dimeric receptor cIL7R and IL15Rd, only when
the trimeric complex IL7/IL7Rα/γc is internalised, downstream signalling is initiated, as discussed in Section 4 cin
Section 5.2 we discuss receptor internalisation in greater detail from a mathematical modelling perspectived. Thus,
the presence of IL15 can, indirectly, sequester γc and, reduce IL7R signalling. Note that we denote by IL7R, the
hetero^dimeric receptor composed of one molecular unit of γc and one molecular unit of IL7Rα, and by IL15R, the
hetero^dimeric receptor composed of one molecular unit of γc and one molecular unit of IL15Rβ. In this context, it
is important to refer to the recent work by the groups of K. C. García and I. Moraga, who have been able to engineer
synthekines, namely, engineered ligands, that produce “unnatural” receptor pairings, yet activate distinct signalling
programmes e63f. In Fig. 1 we show one such potential synthekine, formed by IL7 and IL15, and denoted IL7.15.
In this paper, we do not consider ligand^induced receptor dimerisation cfor simplicity, and assume both receptor
chains have already formed the hetero^dimeric receptor before ligand bindingd, although, it may be relevant for some
combinations of γc and cytokine receptors e18f.
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5.1.1 Mathematical model
Following Ref. e22f, we model the dynamics of free IL7 and IL15 cytokines cor ligandsd, the receptor subunits γc,
IL7Rα and IL15Rβ and the ccomplexd hetero^dimeric receptors IL7R and IL15R, either bound or unbound to their
respective ligands. We note that in this review, we do not consider the presence of synthetic ligand IL7.15. We con^
sider the molecular reactions described in Fig. 1, which include the association and dissociation of diôerent receptor
chains, as well as the association and dissociation of ligand cIL7 or IL15d to the hetero^dimeric receptors IL7R and
IL15R, respectively. We are interested in understanding how the concentrations of these molecular species evolve in
time. This is described in Ref. e22f by the following system of ordinary diôerential equations cODEsd
deIL7Rαf
dt
= −kf,1eIL7Rαfeγcf + kr,1eIL7Rfu ,
deIL15Rβf
dt
= −kf,2eIL15Rβfeγcf + kr,2eIL15Rfu ,
deγcf
dt
= −kf,1eIL7Rαfeγcf + kr,1eIL7Rfu − kf,2eIL15Rβfeγcf + kr,2eIL15Rfu ,
deIL7Rfu
dt
= kf,1eIL7Rαfeγcf − kr,1eIL7Rfu − kf,3eIL7feIL7Rfu + kr,3eIL7Rfb ,
deIL15Rfu
dt
= kf,2eIL15Rβfeγcf − kr,2eIL15Rfu − kf,4eIL15feIL15Rfu + kr,4eIL15Rfb ,
deIL7Rfb
dt
= kf,3eIL7feIL7Rfu − kr,3eIL7Rfb ,
deIL15Rfb
dt
= kf,4eIL15feIL15Rfu − kr,4eIL15Rfb .
deIL7f
dt
= −kf,3eIL7feIL7Rfu + kr,3eIL7Rfb ,
deIL15f
dt
= −kf,4eIL15feIL15Rfu + kr,4eIL15Rfb .
These equations can be solved for diôerent initial conditions of ligand concentration of IL7 and IL15, as well as
diôerent number of receptor chains cγc, IL7Rα and IL15Rβd e22f csee Table 1d. The table below provides the values
of the association and dissociation rates considered in the model e22f, and the diôerent initial conditions that have
been considered.
parameter value units
ρ ccell densityd 105 cells/µL
eIL7f(t = 0) 10−1 − 103 nM
eIL15f(t = 0) 10−1 − 103 nM
eIL7Rαf(t = 0) 103 cell−1
eIL15Rβf(t = 0) 103 cell−1









Table 1: Summary of parameters used in the molecular model of Section 5.1. Parameter values have been taken from
Ref. e58f.
In Fig. 2 cleft plotd we show the eôect of the initial concentration of IL7, eIL7f(t = 0), on the steady state value of
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Fig. 2 cmiddle plotd shows the eôect of the initial concentration of IL15, eIL15f(t = 0), on f7. We note that f7
decreases as the initial concentration of eIL15f(t = 0) increases, as expected. The green curve in Fig. 2 can be
reproduced using the language BioNetGen e64, 65, 66f and the listing in Appendix A. Minimal modifications of
the code will allow the reader to obtain the rest of the plots in Fig. 2. Finally, the right plot, shows for an initial
concentration of eIL15f = 9.5nM cthe IL15 concentration that yields eIL7Rfb = eIL15Rfb at steady stated, the eôect
of the initial value of γc chain expression on the steady state values of eIL7Rfb and eIL15Rfb.

























































Figure 2: Left plot: fraction of bound eIL7Rfb, f7, as defined by Eq. c1d, for diôerent values of the initial concentration
of eIL7f(t = 0). Diôerent colours correspond to diôerent values of the initial concentration of eIL15f(t = 0), as
shown in the legend. Middle plot: fraction of bound eIL7Rfb, f7, as in the left panel, but as a function of the initial
concentration of eIL15f(t = 0). Right plot: steady state values for the bound complexes, eIL7Rfb and eIL15Rfb, as a
function of the initial γc chain expression, γc(t = 0). The parameters have been taken from Ref. e58f and have been
summarised in Table 1.
5.2 Mathematical model at the cellular level
The role of the IL7 receptor in T cell development, homeostasis and diôerentiation has been widely studied and
recognised e19, 67f. IL7Rα cell surface expression on T cells is down^regulated once a T cell has received enough
survival signals mediated by IL7R e19, 12f. To model this so^called altruistic down^regulation of membrane IL7R, we
note that, upon IL7 stimulation, there is rapid IL7Rα internalisation cmediated by endocytosisd, that is accompanied
with a reduced rate of receptor recycling and increased receptor degradation e48f. Thus, we first formulate a simple
mathematical model cfor further details, see Ref. e24fd, which describes the dynamics of the number of ligand molecules
cIL7, in this cased,m1(t), and per cell free^receptor cIL7Rd,m2(t), binding/unbinding to form a receptor̂ ligand bound
complex,m3(t), internalisation, degradation and recycling. We also assume that cell signalling is elicited cand encoded
in the dynamics of the variable, m4(t), which represents a potential unidentified transcription factord, after bound
receptors are internalised, as reported in Ref. e48f. Finally, the altruistic eôect e12f is included as a signal^dependent
synthesis rate e24f. We note that recent experimental evidence suggests that IL7 availability is regulated by innate
lymphoid cells cILCsd, which act as a “cytokine sink” by competing for and consuming IL7 and thus, restricting T cell
homeostasis in lymphoid organs. In fact, ILCs seem to outcompete T cells for IL7 by resisting IL7^mediated IL7R
down^regulation e68f, which would support the idea that ILCs do not behave in an altruistic manner.
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5.2.1 A simple model of altruistic IL7Rα dynamics
Mathematically, we describe the time evolution of the IL7 and IL7R in a cellular model csee Ref. e24fd making use of
a system of ordinary diôerential equations cODEsd, as follows
dm1
dt
= φ+Nc(koff m3 − kon m1 m2) , c2d
dm2
dt






= kon m1 m2 − koff m3 − σb m3 , c4d
dm4
dt
= ψ m3 − χ m4 , c5d
where
• φ is the rate at which free IL7 is replenished in the extra^cellular volume csource termd,
• Nc is the total number of cells cin the experimentd,
• kon and koff are, respectively, the binding and unbinding rates of IL7 and IL7R,
• σu and σb are the internalisation rates of the unbound and bound receptors cfollowing Ref. e48f and Ref. e24f,
we assume σb > σud,
• ξ is the rate at which IL7R receptor is synthesised and transported to the cell membrane,
• κs is the carrying capacity of m4, which accounts for the altruistic eôect. Note that in the limit κs → 0+ we
have perfect altruism cas IL7R synthesis after receptor internalisation is fully inhibitedd. On the other hand, in
the limit κs → +∞, the rate of synthesis is independent of signalling, and thus, there is no altruistic feedback
cas might be the case for ILCs e68fd 1,
• ψ is the rate at which internalised bound receptors elicit a signal cencoded by the potential unidentified tran^
scription factor, m4d, and
• χ is the characteristic degradation rate of the signal cencoded by the potential unidentified transcription factor,
m4d.
5.2.2 Steady state analysis of the cellular model
In steady state, the system of equations, Eq. c2d to Eq. c5d, can be solved analytically. The solution is given by
mss1 =
φ(koff + σb)σu(κsNcσbχ+ φψ)





















These steady state solutions are positive as long as
φ < φthreshold ≡
√
κsN2c σbχ(κsσbχ+ 4ψξ)− κsNcσbχ
2ψ
.
Note that the limit, κs → +∞, in the steady state solutions given above, corresponds to a receptor̂ ligand system in
which no cellular altruistic behaviour is present. Let us now assess the eôect of altruism in the diôerent observables
1If the intra^cellular levels of the potential transcription factor, m4, are such that m4 ≫ κs, the synthesis rate is considerably reduced.
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Parameter Value Units
φ 101 − 108 receptor hour−1





koff/kon 1.7 ng ml−1
ψ 0.61 signal receptor−1 hour−1
χ 0.19 hour−1
Table 2: Parameters of the cellular model taken from Ref. e24f and Ref. e48f.







, the steady state ratio of free cavailable for other
cellsd IL7 in the non^altruistic cκs → +∞d and altruistic cκs ̸= 0d cases, for diôerent values of φ cleft plotd and for







, the steady state ratio of free receptors
cIL7Rd in the non^altruistic cκs → +∞d and altruistic cκs ̸= 0d cases, for diôerent values of φ cleft plotd and for
diôerent values of κs cright plotd. Note the symmetry between Fig. 3 and Fig. 4. This is due to the fact that in steady







which does not depend on the value of κs, the parameter which encodes the level of altruism in the IL7 signalling
system.











































































diôerent values ofNc. Model parameters are summarised in Table 2. Diôerent colours correspond to diôerent values
of the number of cells, Nc, in the experiment.
5.3 Mathematical model at the population level
Naive CD8+ T cells require signalling^mediated by the cytokine interleukin^7 cIL7d for survival and proliferation e67f.
As discussed in Palmer et al. e58f, CD8+ T cells have distinct thresholds for survival and proliferation; that is, a
stronger IL7R^mediated signal is required for proliferation as compared to the strength of signal required for cel^
lular survival. Recent experiments also support the idea that higher CD5 expression correlates with higher IL7R
expression in CD8+ T cells, and indeed CD5hi T cells were found to have more robust responses to IL7 than CD5lo
9








































































for diôerent values of Nc. Model
parameters are summarised in Table 2. Diôerent colours correspond to diôerent values of the number of cells, Nc,
in the experiment.
T cells e58f. On the other hand CD5lo T cells were found to have prolonged survival when compared to CD5hi T cells
in an IL7 independent environment e58f.
In this section, we develop a mathematical model at the population level of immune IL7R^mediated signalling that
considers the heterogeneity of the expression levels observed for CD5 and IL7R. We introduce, thus, four diôerent
CD8+ T cell populations csee Fig. 5d, characterised by their relative expression of these two proteins. We also assume
the total pool of CD8+ T cells exists within a well^mixed system, such that there exists a global concentration of IL7.
Thus, we neglect any spatial heterogeneities. T cells may receive signals for survival or proliferation depending on
the amount of available extra^cellular IL7 and their relative IL7R surface expression. Since we are considering the
dynamics of T cells at the population scale, we assume the eôects of localised IL7 production and consumption at
the single cell scale, are eôectively “averaged out” allowing the modelling eôort to give a reasonable description of
the population dynamics e22, 24f.
The physical size of the IL7 protein is much smaller than the size of a T cell and typically there are many more
of these molecules than T cells in the experimental system. Our measurement of IL7 will therefore not be based
on the number of IL7 molecules, but rather the concentration of IL7 in the extra^cellular medium. Therefore, we
use a deterministic characterisation for the IL7 concentration, instead of a stochastic description, which shall be
introduced to describe the number of T cells in the system. We assume the rate of production of IL7 is independent
of the number of T cells e69f, and for the purposes of this model, we will assume the rate of IL7 production to be
constant. We also assume the rate of consumption of IL7 is proportional to the product of the concentration of
IL7 and the number of T cells expressing IL7R, due to the internalisation of ligand^receptor bound complexes csee
Section 5.1d. The constants of proportionality are greater/lower for IL7Rhi/IL7Rlo T cells, respectively. We further
assume that the four diôerent T cell populations have a basal IL7^independent death rate. This death rate is greater
for CD5hi T cells than for CD5lo T cells e58f. However this death rate does not depend on the level of IL7R expression
csee Fig. 5d. The death rate is switched on if IL7 availability is below a given survival threshold and equivalently, it is
switched oô if the concentration of IL7 is above this threshold e58f. Similarly, if the concentration of IL7 is above a
given proliferation threshold, we turn on a proliferation term for IL7Rhi T cells. Following a division event IL7Rhi
T cells produce two daughter cells, in the corresponding IL7Rlo pool, in consonance with the altruistic hypothesis.
We assume IL7Rlo T cells may not receive su~cient IL7 stimulus to undergo a division event. IL7Rlo T cells are
assumed to up^regulate their expression levels of IL7R and become IL7Rhi csee Fig. 5d. Lastly, we assume the level
of CD5 expression is invariant; that is, CD5hi cells can only increase or decrease their levels of IL7R expression, but
maintain their high level of CD5 expression constant. The same is true for CD5lo cells csee Fig. 5d. The interplay
between IL7 receptor expression and signalling on the fate cdivision, proliferation or IL7R up^regulationd of the four
diôerent population of CD8+ T cells can be captured mathematically and will be discussed in the following section.
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Figure 5: Immune signalling at the population level: possible transitions between the four subsets of the peripheral
CD8+ T cell pool. We impose µ1 > µ2; that is, CD5lo T cells have prolonged survival in a cytokine independent
environment. In the mathematical model the parameter λ corresponds to the per cell division rate. λ1 is the per cell
division rate for CD5hi CD8+ T cells and λ2 is the per cell division rate for CD5lo CD8+ T cells, with λ1 > λ2 e58f.
We assume that after a division event, there is a significant drop in the level of IL7R expressed on the surface of
a cell, since daughter cells inherit, on average, half of the IL7 receptors expressed by their mother cell. Finally,
φ corresponds to the basal up^regulation rate of IL7R expression and is assumed to be independent of the extra^
cellular IL7 concentration. φ1 is the per cell IL7R up^regulation rate for CD5hi CD8+ T cells and φ2 is the per cell
IL7R up^regulation for CD5lo CD8+ T cells.
5.3.1 Mathematical model
We denote by ni,j the number of cells in subset Si,j : an index value of “1” always refers to “high”, whereas an index
of “2” always refers to “low”. If a pair of indexes appears in a variable, the first one refers to CD5 and the second to






We now describe the dynamics that characterise the four diôerent population of CD8+ T cells and that are driven
by IL7 signalling.
Dynamics of IL7 We model the concentration of IL7 in a deterministic manner, as we argued above. Let I denote
the concentration of IL7. We assume IL7 is produced at a constant rate ν, independent of its extra^cellular level e9, 7f.
We also consider IL7 loss, due to internalisation of IL7 once it binds IL7R expressed on the surface of T cells. We,
thus, assume that this loss term is proportional to the global concentration of IL7 and the number of T cells. These
terms then take the form
−γ1(n1,1 + n2,1)I − γ2(n1,2 + n2,2)I ,
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where γ1 > γ2, since we assume IL7Rhi cells internalise IL7 at a faster rate than IL7Rlo cells, since their IL7R surface
expression levels are higher by construction. The concentration of IL7 then obeys an ODE of the form
dI
dt
= ν − γ1(n1,1 + n2,1)I − γ2(n1,2 + n2,2)I . c11d
Dynamics of T cells The populations of CD8+ T cells are modelled in a stochastic fashion. Let us introduce a
threshold for survival θs and a threshold for proliferation θp e58, 24f. We shall assume the dimensions of θs and θp
to be those of I , i.e., volume concentration. We assume that the survival threshold is lower than the proliferation
one e24f; that is, θs < θp. We now describe the CD8+ T cell dynamics, as follows:
• If I < θs cdeath eventd:
ni,j → ni,j − 1, in a small time interval, ∆t, with probability µi ni,j ∆t for i, j = 1, 2.
• If θs < I < θp csurvival eventd:
ni,j → ni,j , in a small time interval, ∆t, with probability one for i, j = 1, 2.
• If θp < I cproliferation eventd:
ni,1 → ni,1 − 1
ni,2 → ni,2 + 2
}
in a small time interval, ∆t, with probability λi ni,1 ∆t for i = 1, 2.
• Finally, and given that the up^regulation of IL7R is independent of the concentration of IL7, this transition
takes the form:
ni,2 → ni,2 − 1
ni,1 → ni,1 + 1
}
in a small time interval, ∆t, with probability φi ni,2 ∆t for i = 1, 2.
These transitions are illustrated in Figure 5.
Threshold function We assume the probabilities of death and proliferation events to be non^zero only when the
concentration of IL7 is below or above the respective threshold functions for survival and proliferation. The exis^
tence of these survival and proliferation thresholds have been experimentally observed e58f. We, therefore, choose a
function such that when the concentration is above or below a certain threshold, it is either 0 or 1. One such suitable








We choose the dimensions of α to be inverse concentration, such that the value of fs(I) is a dimensionless quantity
bounded between 0 and 1. This threshold function is then included within the previously defined transition proba^
bilities for death and proliferation events. If f•(I) ≈ 0, then the probability of the given event is close to zero and
the event is eôectively turned oô. Similarly if f•(I) ≈ 1, then the probability of the event is turned on.
The parameter α modulates the severity of the threshold function. In particular, if α → +∞, the threshold is ex^











0 if I > θs ,
1/2 if I = θs ,
1 if I < θs .
In Fig. 6 we show the threshold functions csee Eq. c12dd for diôerent values of α. In the limit α→ 0+, the thresholds
disappear and T cell proliferation and death events do not depend on the amount of free IL7 available. On the other
hand, in the limit α→ +∞ the
5.3.2 Numerical results
We have implemented the model discussed in Section 5.3.1, making use of a deterministic characterisation cODEd for
the concentration of IL7, I(t), and either an ODE model for the number of cells in each compartment or a stochastic
Markov description, which requires the implementation of a Gillespie algorithm csee code provided in Appendix Bd.
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Figure 6: Eôect of the parameter α on the severity of the threshold functions csee Eq. c12dd. Note that for α = 0
cblack lined the threshold functions are constant and equal to 12 . On the other hand, for α ≫ 1 the functions are
almost discontinuous and the thresholds rather sharp.
The deterministic model for the four T cell populations and the concentration of IL7 is described in the code pro^
vided in Appendix C. The parameters used in the numerical studies have been summarised in Table 3. When other
parameter values have been used, we have provided their values explicitly. To model diôerent extra^cellular signalling
environments, describing diôerent values of extra^cellular IL7 concentration, we vary the value of the parameter ν,
and make use of a so0 threshold given by α = 5. As shown in Figs. 7^9, diôerent values of ν change the steady state
of the four T cell populations. In all cases, on the right panel we show the relative number of T cells with high
cblack linesd and low cred linesd expression of CD5. In that panel we also show two diôerent stochastic simulations
to emphasise the role of fluctuations when the number of cells is small cin all cases we have considered that, initially,
there is a total of 200 cells, equally distributed between the four compartmentsd. For completeness, in Fig. 10 we
consider the case where IL7 is removed from the system not only by IL7 receptor̂ mediated internalisation but by
other mechanisms cthat we denote generically, degradationd, for the same parameter values as those of Fig. 9. Note
that, while the maximum level of IL7 changes significantly, the dynamics of the CD8+ T cell populations does not
qualitatively change.
Figure 7: Numerical study for a total time of two weeks with low IL7 production, ν = 1 and a so0 threshold, α = 5.
On the right plot, we see the T cell population is dominated by the subset of CD5lo T cells. Note the reasonable
agreement between the deterministic model cODEd and the stochastic simulations cSSAd. On the left plot, we follow
the extra^cellular IL7 concentration in time. On the middle plot, we follow the four cellular populations in time. On
the right plot, we follow the two cellular populations, as defined by their CD5 expression in time.
From these numerical studies, two significant conclusions can be derived. First of all, diôerent values of ν cthe
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parameter value units reference
I(0) 1 econf Note 1
n1,1(0) 50 cells This work
n1,2(0) 50 cells This work
n2,1(0) 50 cells This work
n2,2(0) 50 cells This work
ν 50 econf−1hour−1 Note 2 e24f
γ1 0.08 hour−1 e24f
γ2 0.02 hour−1 Chosen to be ∼ γ1/4
µ1 0.027 hour−1 e24f
µ2 0.018 hour−1 Chosen to be = 2µ1/3
λ1 0.083 hour−1 e24f
λ2 0.055 hour−1 Chosen to be= 2λ1/3
φ1 0.083 hour−1 Chosen to be = λ1
φ2 0.042 hour−1 Chosen to be ∼ φ1/2
θs 0.8 econf This work
θp 1.5 econf This work
α 5 econf−1 Note 3
δ 20 h−1 e24f
Table 3: Parameters for the population model of IL7^mediated signalling. Note 1: we normalise the initial concentra^
tion of IL7 to 1. This allows us to use generic units of concentration ceconfd rather than the standard M cmoles/litred.
Note 2: we have normalised ν from Ref. e24f according to Note 1. Note 3: in order to guarantee a threshold^like
response, we have chosen a relatively large value of α.
Figure 8: Numerical study for a total time of two weeks with medium IL7 production, ν = 5 and a so0 threshold,
α = 5. On the right plot, we see the T cell population is dominated by the subset of CD5lo T cells. Note that
a deterministic cODEd approach cannot precisely reproduce the stochastic behaviour cSSAd. On the left plot, we
follow the extra^cellular IL7 concentration in time. On the middle plot, we follow the four cellular populations in
time. On the right plot, we follow the two cellular populations, as defined by their CD5 expression in time.
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Figure 9: Numerical study for a total time of two weeks with high IL7 production, ν = 25 and a so0 threshold, α = 5.
On the right plot, we see the T cell population is dominated by the subset of CD5hi T cells. Note that a deterministic
cODEd approach is able to reproduce the stochastic behaviour cSSAd. On the left plot, we follow the extra^cellular
IL7 concentration in time. On the middle plot, we follow the four cellular populations in time. On the right plot,
we follow the two cellular populations, as defined by their CD5 expression in time.
Figure 10: Numerical study for a total time of two weeks with high IL7 production, ν = 25 and a so0 threshold, α = 5.
This study also considers the role of IL7 degradation cwith rate δ = 20 h−1d. On the right plot, we see the T cell
population is dominated by the subset of CD5lo T cells. Note that a deterministic cODEd approach cannot precisely
reproduce the stochastic behaviour cSSAd observed. On the left plot, we follow the extra^cellular IL7 concentration
in time. On the middle plot, we follow the four cellular populations in time. On the right plot, we follow the two
cellular populations, as defined by their CD5 expression in time.
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parameter that encodes the IL7 extra^cellular environmentd lead to diôerent relative fractions of cells with high and
low expression of CD5. These results are in agreement with the experimental evidence summarised by Palmer et
al. e58f. These authors observed population dominance in favour of CD5hi CD8+ T cells in high IL7 environments.
In contrast, CD5lo CD8+ T cells were observed to dominate the T cell repertoire in low IL7 environments. In
between these, at physiological levels of IL7, an equal balance in the T cell repertoire was observed e58f. Secondly,
the striking result that the deterministic approximation cODEd cannot capture the switch between low and high IL7
extra^cellular environments occurring for intermediate values of ν csee, for instance, the right panel in Fig. 8d. This
discrepancy between the deterministic and the stochastic descriptions raises a potential methodological concern;
namely, how to choose the value of α. We note that these diôerences originate from two possible eôects: the value
of ν and that of α. The first eôect is easier to understand, since very large values of ν csee, for instance, Fig. 9d drive
the cytokine concentration, I , to its deterministic value and stochastic fluctuations are damped out quickly ccompare
the left plots of Fig. 7 and Fig. 8 to the left plot of Fig. 9d. In order to decipher the role of α, we first note that when
α = 0, the T cell populations do not perceive any IL7 threshold behaviour and their dynamics is independent of
the amount of free extra^cellular IL7 available. Secondly, let us now evaluate the eôect of diôerent values of α cand
the severity of the thresholdsd in the dynamics of the four T cell populations. Fig. 11 reproduces the simulations of
Fig. 8 for α = 0 ctopd and α = 50 cbottomd. As discussed above, the case α = 0 is not biologically relevant, since the
IL7 survival and proliferation thresholds have been observed in experiments e58f. Furthermore, for the death and
proliferation rates obtained in Ref. e24f, and in the absence of IL7 survival and proliferation thresholds, the number
of T cells increases indefinitely csee middle panel of the top row in Fig. 11d. Finally, a comparison between the cases
α = 5 csee Fig. 8d and α = 50 csee bottom row of Fig. 11d shows that sharper threshold functions decrease the size of
the stochastic fluctuations.
In order to further dissect our latter claim, in Fig. 12 we show the histogram of stochastic steady states for ν = 5
and for α = 5 or α = 50. Remarkably, the histogram is so wide that it contains stochastic realisations where
there is a switch between the CD5hi and CD5lo populations, that cannot be predicted by the deterministic model.
This behaviour suggest that, the combination of non^linearities cin our case the threshold functionsd and a stochas^
tic description, leads to richer outcomes than traditional deterministic approaches. It is beyond the scope of this
manuscript to study in greater depth the interplay between stochasticity and threshold responses. Yet, we feel this
interplay deserves further analysis since it has not been comprehensively addressed in the literature.
6 Dysregulation of IL7 receptor expression and signalling in cancer
and inflammation
Direct evidence for the importance of understanding IL7R Biology comes from clinical settings where dysregulation
of IL7R expression or signalling were found to be linked with autoimmune inflammatory diseases and tumourigene^
sis e70, 71f. Both gain^ and loss^of^function mutations in the IL7Rα gene have been reported, and there are strong
associations between dysregulation of IL7R expression and multiple inflammatory diseases, but also cancer e72, 73f.
Along these lines, about 10i of pediatric T^ALL patients displayed gain^of^function mutations in IL7Rα, which
caused ligand^independent activation and signalling of IL7R e74, 75, 76f. Most of these mutations were found in
exon 6 of the IL7Rα gene, at sites that corresponded to the membrane^proximal region of the extra^cellular domain
of the receptor. These mutations could cause homo^dimerisation of IL7Rα molecules as they introduced, among
others, new cysteine residues which could form disulfide linkage with other mutated IL7Rα proteins. Remark̂
ably, in these tumour cells, IL7Rα homo^dimerisation was su~cient to induce ligand independent IL7Rα signalling,
resulting in constitutive STAT5 phosphorylation and activation e74f. Interestingly, earlier studies indicated that
homo^dimerisation of IL7Rα could not trigger IL7R signalling and that signalling required hetero^dimerisation with
γc receptors, presumably because JAK1 activation required the trans^phosphorylation by JAK3 e11f. Why and how
IL7Rα mutations in ALL tumour cells can induce productive signalling by IL7Rα homo^dimerisation is an intense
area of research, and insights from structural biology in conjunction with mathematical modelling are expected to
shed light on these open and challenging questions.
As a potential explanation, a recent study suggested the role for IL7Rα trans^membrane domains in the spatial re^
organisation of mutant IL7Rα homo^dimeric proteins e77f. Under normal circumstances, IL7Rα homodimers would
dimerise into a configuration where the intra^cellular domains would all face the same direction and JAK1 molecules
would not be juxta^positioned and face each other for trans^phosphorylation. In some IL7Rα mutants, however,
twists in the trans^membrane domain would cause rotations of the intra^cellular region which would position JAK1
molecules into the correct orientation for trans^phosphorylation and activation e78f.
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α = 0 ν = 5
α = 50 ν = 5
Figure 11: Numerical study for a total time of two weeks with high IL7 production, ν = 5 for two values of α: α = 0
ctop rowd and α = 50 cbottom rowd. On the left plot, we follow the extra^cellular IL7 concentration in time. On the
middle plot, we follow the four cellular populations in time. On the right plot, we follow the two cellular populations,
as defined by their CD5 expression in time.
17
α = 5 ν = 5 α = 50 ν = 5
Figure 12: Histogram of the steady state of CD5 high subpopulation cblackd and CD5 low subpopulation credd for
ν = 5 and α = 5 cleftd or α = 50 crightd. The blue dashed vertical line is a guide to the eye to show the line where
the fraction of each subpopulation is 50i.
Beyond the implications in tumour biology, these findings raise many challenging questions, such as why persistent
IL7R signalling would not suppress expression of the oncogenic IL7Rα and how mutant IL7Rα expression would
aôect conventional IL7Rα signalling, for example. In parallel to biochemical and cellular approaches, we suggest
exploiting the power of mathematical and computational modelling, as presented in this review, to enhance our
quantitative understanding of these complex immune signalling problems.
7 Discussion
This review is based on the hypothesis that the development of suitable mathematical models of immune signalling
and receptor tra~cking will allow us to provide answers to some current health^related challenges: how does the
expression level cor its copy numberd of a given protein in an immune receptor signalling pathway cor networkd aôect
the type and timescale of cellular responses and how does ligand concentration or protein competition for binding
sites on immune receptors drive diôerent cellular fates by turning on/oô diôerent intra^cellular mechanisms, such
as endocytosis, degradation, recycling or protein synthesis. From a mathematical perspective, the challenge is to
develop a quantitative approach to how receptor̂ ligand signalling regulates cellular fate that cid integrates a wide
range of molecular, cellular and population data, and ciid improves our understanding of the mechanisms that are
dysregulated in disease, so that the mathematical models are accurate predictors of response to receptor̂ targeted
therapies and can aid the design of novel drugs. In this regard, the ability to synthetically create ligands creferred to
as symthekines e63fd, with the ability to bring together receptor chains that are not naturally paired together, opens
a door to novel ways to tune immune signalling. For instance, a dimeric compound of IL7 and IL15 creferred to as
IL7.15 in Fig. 1d, with the ability to bring together IL7Rα with IL15Rβ, can modulate IL7R and IL15R signalling, and
thus T cell behaviour. Our belief is that mathematical modelling can help quantify, and even predict, the extent of
this immune signalling modulation as a function of IL7 and IL15 extra^cellular concentration.
In the last decade a lot of quantitative work has supported the view that IL7 and its receptor, IL7R, are one of the
master regulators of T cell homeostasis e19, 67f. Still a number of questions remain open, as discussed in this review.
One of these challenges relates to intra^cellular events that take place once IL7R has been internalised. While much
of the emphasis is often placed at the ligand^receptor level, tra~cking, degradation, recycling and receptor synthesis
are crucial to understanding how receptor̂ mediated signalling regulates immune cell fate. Thus, there is a need to
develop mathematical models of immune signalling that incorporate receptor tra~cking events e24, 62f. Recent
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experimental advances e79f together with novel mathematical models will be essential to enhance our understanding
of the mechanisms that regulate receptor̂ mediated immune signalling, and in turn will allow us to decipher how
signalling determines immune cellular fate.
Finally, in this review we have presented a number of mathematical models, each of them at a diôerent level of
description cmolecular, cellular and population, respectivelyd. A current challenge and opportunity for applied math^
ematics is to integrate the diôerent scales involved in the biological system under consideration. In this direction,
agent^based models e80f are good candidates, as they bring together the characteristics of single cells with the dy^
namics of the whole population. Agent^based models, in combination with traditional mathematical models cbased
for instance in ODEs, as we discussed in Section 5.3d, enable us to integrate diôerent timescales.
We conclude with a reference to some recent work which has highlighted the relevance and significance of mathe^
matical modelling in Immunology e81f. This latter reference has collected a number of studies of T cell immunology
to illustrate the benefits of theoretical and experimental collaborations, not only at the receptor and signalling level,
as we have done in this review.
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A Code listing for molecular level model dsee Section 5.1e
beg in model
beg in parameter s
NA 6 . 0 2 2 1 4 e23 # m olecu le s per mol c Avogadro c o n s t a n t d
c e l l D e n s i t y 1 e 1 1 # c e l l s per L c 1 e5 c e l l s per uL d
Vecf = 1 / c e l l D e n s i t y
# c o n c e n t r a t i o n of IL−7 a t time t =0
dens7 1 # nM c used f o r p a r a m e t r i c p l o t d
IL7_0 dens7 * 1 . 0 e−9*cNA* Vecf d # M converted to c o p i e s per c e l l c cpc d
# c o n c e n t r a t i o n of IL−15 a t time t =0
d e n s 1 5 0 . 10 # nM c used f o r p a r a m e t r i c p l o t d
IL15_0 d e n s 1 5 * 1 . 0 e−9*cNA* Vecf d # M conver ted to c o p i e s per c e l l c cpc d
# number of r e c e p t o r s per c e l l
IL7Ralpha_0 1 . 0 e3 # cpc
IL15Rbeta_0 1 . 0 e3 # cpc
g0 1 . 0 e3 # c used f o r p a r a m e t r i c p l o t d
gammac_0 g0 # cpc
# React ion r a t e s c f : forward / r : backward d
k f 1 1 . 0 e9 / cNA* Vecf d # i n u n i t s of M^ g − 1 h min ^ g − 1 h conver ted to / c m o lecu le s / c e l l d / s
k r 1 0 . 1 # in u n i t s of min ^ g − 1 h
k f2 1 . 0 e9 / cNA* Vecf d # in u n i t s of M^ g − 1 h min ^ g − 1 h conver ted to / c m o lecu le s / c e l l d / s
kr2 0 . 1 # in u n i t s of min ^ g − 1 h
k f 3 1 . 0 e9 / cNA* Vecf d # i n u n i t s of M^ g − 1 h min ^ g − 1 h conver ted to / c m o lecu le s / c e l l d / s
k r3 0 . 1 # i n u n i t s of min ^ g − 1 h
kf4 0 . 1 * 1 . 0 e9 / cNA* Vecf d # i n u n i t s of M^ g − 1 h min ^ g − 1 h conver ted to / c m o lecu le s / c e l l d / s
kr4 0 . 1 # i n u n i t s of min ^ g − 1 h
end parameter s
beg in molecu le t y p e s
IL7 c r , r d # IL−7 c l i g a n d to be bound to r e c e p t o r s i t e ” r ” d
IL15 c r , r d # IL−15 c l i g a n d to be bound to r e c e p t o r s i t e ” r ” d
IL7Ralpha c r , l d # IL−7Ralpha r e c e p t o r c a t t a c h to gammac v i a ” r ” or l i g a n d v i a ” l ” d
IL15Rbeta c r , l d # IL−5Rbeta r e c e p t o r c a t t a c h to gammac v i a ” r ” or l i g a n d v i a ” l ” d
gammac c r , l d # gammac c a t t a c h to gammac v i a ” r ” or l i g a n d v i a ” l ” d
end molecu le t y p e s
beg in seed s p e c i e s
IL7 c r , r d IL7_0
IL15 c r , r d IL15_0
IL7Ralpha c r , l d IL7Ralpha_0
IL15Rbeta c r , l d IL15Rbeta_0
gammac c r , l d gammac_0
end seed s p e c i e s
beg in o b s e r v a b l e s
S p e c i e s Bound7R IL7Ralpha . gammac . IL7
S p e c i e s Bound15R IL15Rbeta . gammac . IL15
end o b s e r v a b l e s
beg in f u n c t i o n s
F r a c t i o n 7 c d = Bound7R / c Bound7R+ Bound15R d
end f u n c t i o n s
beg in r e a c t i o n r u l e s
IL7Ralpha c r , l d + gammac c r , l d <−>IL7Ralpha c r ! 1 , l d . gammac c r ! 1 , l d kf1 , k r 1 # h e t e r o d i m e r i z a t i o n
IL15Rbeta c r , l d + gammac c r , l d <−>IL15Rbeta c r ! 1 , l d . gammac c r ! 1 , l d kf2 , kr2 # h e t e r o d i m e r i z a t i o n
# Binding
IL7Ralpha c r ! 1 , l d . gammac c r ! 1 , l d + IL7 c r , r d <−>IL7Ralpha c r ! 1 , l ! 2 d . gammac c r ! 1 , l ! 3 d . IL7 c r ! 2 , r ! 3 d kf3 , k r 3
IL15Rbeta c r ! 1 , l d . gammac c r ! 1 , l d + IL15 c r , r d <−>IL15Rbeta c r ! 1 , l ! 2 d . gammac c r ! 1 , l ! 3 d . IL15 c r ! 2 , r ! 3 d kf4 , kr4
end r e a c t i o n r u l e s
end model
generate_network c g o v e r w r i t e = > 1 h d ; # Generate network
22
#s i m u l a t e _ o d e c g t_end = >1000 , n _ s t e p s = >100 , p r i n t _ f u n c t i o n s = > 1 h d ; # Get time−co ur se
#parameter_scan c g method=> ” ode ” , par_min = >1 e−1 , par_max = >1 e3 , \
parameter_scan c g method=> ” ode ” , par_min = >1 e0 , par_max = >1 e5 , \
n _ sc a n _ p t s = >50 , l o g _ s c a l e = >1 , t_end = >1000 , n _ s t e p s = >2 , p r i n t _ f u n c t i o n s = > 1 , \
parameter => ” dens7 ” h d # Change by d e n s 1 5 or g0 f o r F i g u r e s 2b−c
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B Code listing for population level stochastic model dsee Section 5.3e
#########################################################################
# S i m u l a t i o n o f IL−7 m o d e l u s i n g G i l l e s p i e a l g o r i t h m and E u l e r m e t h o d f o r
# s o l u t i o n o f ODE g o v e r n i n g IL−7 d y n a m i c s
#########################################################################









mu2 = 0 .0 1 7
lam1 = 0.083
lam2 = 0 .0 5 5
p h i 1 = 0 .083
phi2 = 0.042
kap_s = 0 .8
kap_p = 1 . 5
a l p h a = 5
h = 0.001
dt = 0 .01
t_end = 300# 3 3 5 0 # 7 2
d e l t a = 0 # h ^−1
nu = 50 # 1 , 1 5 , 5 0
n _ s t e p s = i n t c t_end / dt d
def IL7 c n1 , n2 , n3 , n4 , I d :
return nu − gam1 * c n1 + n3 d * I − gam2 * c n2 + n4 d * I − d e l t a * I
def rho_s c I d :
return 1 / c 1 + math . exp c a l p h a * c I − kap_s d d d
def rho_p c I d :
return 1 / c 1 + math . exp c a l p h a * c kap_p − I d d d
X = np . z e r o s c c 6 , n _ s t e p s d d
Xe 0 f e 0 f = I0
Xe 1 f e 0 f = N1
Xe 2 f e 0 f = N2
Xe 3 f e 0 f = N3
Xe 4 f e 0 f = N4







IL = e f
for k in range c 0 , n _ s t e p s d :
while t < k * dt :
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i f n1 == 0 and n2 == 0 and n3 == 0 and n4 == 0 :
break
rmu1 = mu1 * n1 * rho_s c I d
rmu2 = mu1 * n2 * rho_s c I d
rmu3 = mu2* n3 * rho_s c I d
rmu4 = mu2* n4 * rho_s c I d
r l am1 = lam1 * n1 * rho_p c I d
r lam2 = lam2 * n3 * rho_p c I d
r p h i 1 = p h i 1 * n2
r p h i 2 = phi2 * n4
r t o t a l = rmu1 + rmu2 + rmu3 +rmu4+ r l am1 + r lam2 + r p h i 1 + r p h i 2
r 1 = random . random c d
T = − c 1 / r t o t a l d * math . l o g c r 1 d
t += T
r 2 = random . random c d
r 2 = r 2 * r t o t a l
i f 0 <= r 2 < rmu1 :
n1 −= 1
e l i f rmu1 <= r 2 < rmu1 + rmu2 :
n2 −= 1
e l i f rmu1 + rmu2 <= r 2 < rmu1 + rmu2 + rmu3 :
n3 −= 1
e l i f rmu1 + rmu2 + rmu3 <= r 2 < rmu1 + rmu2 + rmu3 +rmu4 :
n4 −= 1
e l i f rmu1 + rmu2 + rmu3 +rmu4 <= r 2 < rmu1 + rmu2 + rmu3 +rmu4+ r l am1 :
n1 −= 1
n2 += 2
e l i f rmu1 + rmu2 + rmu3 +rmu4+ r l am1 <= r 2 < rmu1 + rmu2 + rmu3 +rmu4+ r l am1 + r lam2 :
n3 −= 1
n4 += 2
e l i f rmu1 + rmu2 + rmu3 +rmu4+ r l am1 + r lam2 <= r 2 < rmu1 + rmu2 + rmu3 +rmu4+ r l am1 + r lam2 + r p h i 1 :
n1 += 1
n2 −= 1
e l i f rmu1 + rmu2 + rmu3 +rmu4+ r l am1 + r lam2 + r p h i 1 <= r 2 < r t o t a l :
n3 += 1
n4 −= 1
n _ i t e r = i n t cT / h d
for l in range c 0 , n _ i t e r d :
I = I + h * IL7 c n1 , n2 , n3 , n4 , I d
IL . append c I d
Xe 0 f e k f = I
Xe 1 f e k f = n1
Xe 2 f e k f = n2
Xe 3 f e k f = n3
Xe 4 f e k f = n4
Xe 5 f e k f = n1 + n2 + n3 +n4
x t i c k s = e f
t i c k i n t e r v a l = t_end / c 5 * dt d
for k in range c 0 , 6 d :
x t i c k s . append c k * t i c k i n t e r v a l d
x l a b e l s = e f
t i c k s = t_end / 5
for k in range c 0 , 6 d :
x l a b e l s . append c k * t i c k s d
I x t i c k s = e f
I x t i c k i n t = t_end / c 5 * h d
for k in range c 0 , 6 d :
I x t i c k s . append c k * I x t i c k i n t d
I l a b e l s = e f
I t i c k s = t_end / 5
for k in range c 0 , 6 d :
I l a b e l s . append c k * I t i c k s d
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np . s a v e t x t c ” c o n c e n t r a t i o n . c s v ” , np . t r a n s p o s e cXd , d e l i m i t e r = ” ɚ ” d
np . s a v e t x t c ” I . c s v ” , np . t r a n s p o s e c IL d , d e l i m i t e r = ” ɚ ” d
f i g = p l t . f i g u r e c d
p l t . s u b p l o t s _ a d j u s t c hspace = 1 . 0 d
ax 1 = f i g . add_subp lot c 1 3 2 d
ax 1 . p l o t cXe 1 f , l a b e l = ’CD5ɚHighɚ&ɚIL−7RɚHigh ’ , c o l o r = ’ green ’ d
ax 1 . p l o t cXe 2 f , l a b e l = ’CD5ɚHighɚ&ɚIL−7RɚLow ’ , c o l o r = ’ b lue ’ d
ax 1 . p l o t cXe 3 f , l a b e l = ’CD5ɚLowɚ&ɚIL−7RɚHigh ’ , c o l o r = ’ red ’ d
ax 1 . p l o t cXe 4 f , l a b e l = ’CD5ɚLowɚ&ɚIL−7RɚLow ’ , c o l o r = ’ p u r p l e ’ d
ax 1 . l egend c bbox_to_anchor = c 1 . 0 , 1 . 0 d d
ax 1 . s e t _ x l a b e l c ’ Timeɚ c Hours d ’ d
ax 1 . s e t _ x t i c k s c x t i c k s d
ax 1 . s e t _ x t i c k l a b e l s c x l a b e l s d
ax 1 . s e t _ y l a b e l c ’ C e l l s ’ d
ax3 = f i g . add_subp lot c 1 3 3 d
ax3 . p l o t c cXe 1 f +X e 2 f d /Xe 5 f , l a b e l = ’CD5ɚHigh ’ , c o l o r = ’ b lue ’ d
ax3 . p l o t c cXe 3 f +Xe 4 f d /Xe 5 f , l a b e l = ’CD5ɚLow ’ , c o l o r = ’ red ’ d
ax3 . l egend c bbox_to_anchor = c 1 . 0 , 1 . 0 d d
ax3 . s e t _ x l a b e l c ’ Timeɚ c Hours d ’ d
ax3 . s e t _ x t i c k s c x t i c k s d
ax3 . s e t _ x t i c k l a b e l s c x l a b e l s d
ax3 . s e t _ y l a b e l c ’ C e l l s ’ d
ax3 . s e t _ y l i m c 0 , 1 d
ax2 = f i g . add_subp lot c 1 3 1 d
ax2 . p l o t c IL , c o l o r = ’ b lue ’ d
ax2 . s e t _ x l a b e l c ’ Timeɚ c Hours d ’ d
ax2 . s e t _ x t i c k s c I x t i c k s d
ax2 . s e t _ x t i c k l a b e l s c I l a b e l s d
ax2 . s e t _ y l a b e l c ’ IL−7ɚ Concentrat ion ’ d
p l t . show c d
26
C Code listing for population level deterministic model dsee Section 5.3e
# I n i t i a l v a l u e s :
#m e t a b o l i t e s
i n i t n12 =50
i n i t n22 =50
i n i t n21 =50
i n i t n 1 1 =50
i n i t I = 1
# Fixed Model E n t i t i e s :
param mu1 =0 .028
param a l p h a =5
param kap_s = 0 . 8
param mu2 = 0 . 0 1 7
param lam1 =0 .083
param kap_p = 1 . 5
param lam2 = 0 . 0 5 5
param p h i 1 =0 .083
param phi2 =0.042
param nu = 1 5
param gam1 =0.08
param gam2 =0.02





n 1 1 _ c = n 1 1
#K i n e t i c s :
Funct io =mu1 * n 1 1 _ c / c 1 + exp c a l p h a * c I_c−kap_s d d d
Funct i =mu1 * n12_c / c 1 + exp c a l p h a * c I_c−kap_s d d d
F u n c t i 1 =mu2* n21_c / c 1 + exp c a l p h a * c I_c−kap_s d d d
Funct i 2 =mu2* n22_c / c 1 + exp c a l p h a * c I_c−kap_s d d d
F u n c t i 3 = lam1 * n 1 1 _ c / c 1 + exp c a l p h a * c kap_p−I_c d d d
Funct i4 = lam2 * n21_c / c 1 + exp c a l p h a * c kap_p−I_c d d d
F u n c t i 5 = p h i 1 * n12_c
Funct i6 = phi2 * n22_c
Fun ct i 7 = nu
Funct i8 = c gam1 * c n 1 1 _ c + n21_c d * I_c + gam2 * c n12_c + n22_c d * I_c d
# Equat ions :
dn12 / dt=−Funct i + 2 * Funct i3−F u n c t i 5
dn22 / dt=−Funct i 2 + 2 * Functi4−Funct i6
dI / dt = Funct i7−Funct i8
dn21 / dt=−Funct i 1−Funct i4 + Funct i6
dn11 / dt=−Functio−F u n c t i 3 + F u n c t i 5
done
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